News Home

Will Quoin Pharmaceuticals Ltd - ADR (QNRX) Stay at the Top of the Healthcare Sector?

Friday, August 19, 2022 09:50 AM | InvestorsObserver Analysts
Will Quoin Pharmaceuticals Ltd - ADR (QNRX) Stay at the Top of the Healthcare Sector?

Quoin Pharmaceuticals Ltd - ADR (QNRX) is near the middle in its sector according to InvestorsObserver. QNRX gets an overall rating of 16. That means it scores higher than 16% of stocks. Quoin Pharmaceuticals Ltd - ADR gets a 55 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 16
QNRX has an Overall Score of 16. Find out what this means to you and get the rest of the rankings on QNRX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 16 would rank higher than 16 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Quoin Pharmaceuticals Ltd - ADR Stock Today?

Quoin Pharmaceuticals Ltd - ADR (QNRX) stock is trading at $4.95 as of 9:50 AM on Friday, Aug 19, an increase of $0.04, or 0.81% from the previous closing price of $4.91. The stock has traded between $4.78 and $4.99 so far today. Volume today is less active than usual. So far 99,076 shares have traded compared to average volume of 3,265,797 shares. Click Here to get the full Stock Report for Quoin Pharmaceuticals Ltd - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App